middle.news
How Island Pharmaceuticals Plans to Fast-Track Galidesivir’s FDA Approval
8:43am on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
How Island Pharmaceuticals Plans to Fast-Track Galidesivir’s FDA Approval
8:43am on Thursday 31st of July, 2025 AEST
Key Points
Acquisition of Galidesivir finalized early after due diligence
Galidesivir backed by over US$70 million in US government R&D funding
Focus on Marburg virus application with potential FDA fast-track approval
FDA submission and meeting planned for Q3 and Q4 2025 respectively
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE